Table 2.
First author [ref.] | Year | Study typea | Description | PsA patients who underwent MRI (n) | MRI field strength (T) |
Antoni [3] | 2002 | 1 | Open-label study of infliximab in PsA; dynamic MRI of hands or feet | 10 | 1.5 |
Backhaus [4] | 1999 | 2 | Patients with inflammatory arthritis; MRI of hands | 9 | 0.2 |
Bollow [5] | 1995 | 2 | SpA patients; MRI of sacroiliac joints | Not stated | 1.5 |
Bollow [6] | 2000 | 2 | SpA patients; biopsies compared with MRI of sacroiliac joints | 2 | 1.5 |
Bongartz [7] | 2005 | 5 | Psoriatic onycho-pachydermo periostitis; MRI evaluation | 1 | Not stated |
Cantini [8] | 2001 | 4 | Distal pitting oedema; MRI evaluation | 7 | 0.5 |
Cimmino [9] | 2005 | 4 | PsA and RA patients; dynamic MRI of wrists | 15 | 0.2 |
Giovagnoni [10] | 1995 | 2 | PsA and RA patients; MRI of hands | 28 | 1.0 |
Godfrin [11] | 2003 | 3 | SpA patients with entheseal pain; MRI of entheses | 5 | 1.5 |
Jevtic [12] | 1995 | 2 | RA and SpA patients; MRI of hands | 6 | 2.3 |
Maillefert [13] | 2003 | 3 | Patients with inflammatory arthritis; MRI of hindfoot | 1 | 1.5 |
McGonagle [14] | 1998 | 2 | SpA and RA patients with knee effusion; MRI evaluation | 3 | 0.5 and 1.5 |
McGonagle [15] | 2002 | 2 | Patients with plantar fasciitis (SpA and mechanical); MRI of entheses | 4 | 0.5 and 1.5 |
Melchiorre [16] | 2003 | 2 | PsA and RA patients; MRI of temporomandibular joint | 11 | 0.5 |
Muche [17] | 2003 | 2 | SpA patients; MRI of sacroiliac joints | 5 | 1.5 |
Offidani [18] | 1998 | 4 | Patients with psoriasis and no joint pain; MRI of hands | 25 | 1.0 |
Olivieri [19] | 1996 | 2 | SpA patients with dactylitis; MRI of fingers | Not stated | 0.5 |
Olivieri [20] | 1997 | 2 | SpA patients with dactylitis of the toes; MRI of toes | 6 | 0.5 |
Olivieri [21] | 2002 | 2 | PsA patients with dactylitis of the fingers; MRI of fingers | 6 | 1.5 |
Olivieri [22] | 2003 | 5 | PsA Patient with dactylitis of fingers; MRI of fingers | 1 | Not stated |
Padula [23] | 1998 | 5 | Patients with dactylitis; MRI evaluation | 2 | Not stated |
Padula [24] | 1999 | 5 | Patient with psoriasis and tenosynovitis; MRI evaluation | 1 | Not stated |
Salvarani [25] | 1999 | 5 | Patients with peripheral pitting oedema; MRI evaluation | 2 | Not stated |
Savnik [26] | 2001 | 2 | Patients with inflammatory arthritis; high field versus low field MRI of wrists and fingers | Not stated | 0.2 and 1.5 |
Savnik [27] | 2001 | 2 | Patients with inflammatory arthritis (RA and SpA); MRI of wrists and fingers | 8 | 1.5 |
Savnik [28] | 2002 | 3 | Patients with inflammatory arthritis (RA and SpA); MRI of wrists and fingers, at baseline and after 1 year | Not stated | 0.2 and 1.5 |
Taylor [29] | 1997 | 5 | PsA patient with enthesitis of elbow; MRI evaluation | 1 | Not stated |
Tehranzadeh [30] | 2004 | 2 | Patients with inflammatory arthritis; MRI of hand evaluated for large bony lesions | 7 | 1.5 |
Tuzun [31] | 1996 | 5 | Psoriatic spondylitis mimicking spinal brucellosis; MRI of spine | 1 | Not stated |
Williamson [32] | 2004 | 2 | PsA patients with clinical features of sacroiliitis; MRI of sacroiliac joints | 68 | 1.0 |
a1, Clinical trial; 2, Observational, cross-sectional; 3, Observational, longitudinal; 4, Case-control; 5, Case report. MRI, magnetic resonance imaging; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, spondyloarthropathy.